Drug intelligence / Profile preview

Cortichlor

Development stage
Unknown
Lead developer
Optho Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Cortichlor is a topical ophthalmic combination medication containing the broad-spectrum antibiotic chloramphenicol and the corticosteroid hydrocortisone (as hydrocortisone acetate). Developed by Optho Pharma, it is formulated as an eye ointment or gel. Chloramphenicol acts by reversibly binding to the 50S subunit of bacterial ribosomes, thereby inhibiting peptidyl transferase and preventing bacterial protein synthesis. Hydrocortisone acts as an agonist of the glucocorticoid receptor, suppressing the local inflammatory response, reducing capillary permeability, and alleviating symptoms such as redness, swelling, and itching. Cortichlor is indicated for the treatment of ocular inflammation accompanied by secondary bacterial infection or risk of infection, including conditions such as conjunctivitis, blepharitis, uveitis, and post-surgical ocular inflammation.

Brand names
Cortichlor
Other names
chloramphenicol + hydrocortisonechloramphenicol + hydrocortisone acetate
02

Targets

Bacterial 50S ribosomal subunitGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Cortichlor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortichlor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call